Gujarat Themis Biosyn informs about revised disclosure

27 Jul 2021 Evaluate
In furtherance to letter dated 26th July, 2021, Gujarat Themis Biosyn has informed that it enclosed the revised disclosure under Regulation 10(5) of SAST 2011, as required. In the revised disclosure filed, there is a correction made in point no 11 thereof.

The above information is a part of company’s filings submitted to BSE.

Guj. Themis Biosyn Share Price

315.65 -25.15 (-7.38%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×